INC Research, a contract research organization (CRO), has officially implemented its Trusted Process in all of its current clinical trial programs. The Trusted Process is a series of phases that proactively lead customers through their drug and device development programs with repeatable and measurable methodology. As a result, INC Research minimizes trial risk factors and customers experience a high level of confidence to make informed decisions with their study data and analysis. “We are continually improving our methods, assessing metrics and setting higher standards to remove variability from our customers’ development programs. Our Trusted Process is more than just adding names to the steps of a trial. For us, it is the way we do business,” said Jim Ogle, CEO at INC Research.

SAS recently announced that the company has extended its commitment to the life sciences industry by forming the SAS health and life sciences global practice. This new division has been established to serve the growing need for technology and solutions that will further fuel the convergence of health care providers, health plans and biopharmaceutical companies. “The ability to harness synergies all across the value chain is redefining the health industry,” says Chris Connor, senior research analyst at Health Industry Insights, an IDC. “We see incredible opportunities in connecting clinical research and health care by integrating electronic data capture (EDC) and electronic health records (EHR). The SAS health and life science global practice will help their customers to identify opportunities not only from the bench to the bedside, but from the bench to the bank.”

Image Solutions (ISI), a clinical and regulatory submissions software company, is helping life sciences companies meet the standards for the eCTD (electronics consortium technical document). ISI has released its newest version of ISIPublisher. It helps support varying electronic submissions in multiple jurisdictions, as well as fulfill the paper requirements for countries that still require them. ISIPublisher is best suited to support the staged approach: it enhances and streamlines paper-publishing operations and enables users to publish reports, submissions, or any electronically available documents that require professional printing.

GeneGo, a systems biology tools company, recently announced that Monarch LifeSciences, a provider of services in protein biomarker discovery, development and validation for the pharmaceutical and biotech industries, will be offering pathway analysis add on services to their customers. The “1-2-3 Workflow” from GeneGo automatically uploads proteomics data; compares the datasets; identifies common, similar and unique components of the datasets; conducts enrichment analysis in multiple ontologies such as diseases, canonical pathways and functional processes and calculates the most relevant networks and focal hub proteins. The end product is a comprehensive Word report. “Our goal is to provide our customers with reliable proteomics data that can easily integrate into their research programs,” said Lauri Caviston, Monarch LifeSciences’ VP of business development. “GeneGo provides an excellent tool for taking the data we generate to the next level.”

Have a news release? Send it to .(JavaScript must be enabled to view this email address). Need to deliver your marketing message to the most focused, dedicated online readership in the clinical trial community?  Talk to .(JavaScript must be enabled to view this email address) about advertising on ClinPage: (857) 233-0168 x103.